(Q53168250)

12 May 2018

title

Poor reporting of quality of life outcomes in dermatology randomized controlled clinical trials. (English)

1 reference

12 May 2018

1 reference

1

Laurence Le Cleach

1 reference

12 May 2018

author name string

Olivier Chassany

2

1 reference

12 May 2018

Annabelle Levy

3

1 reference

12 May 2018

Pierre Wolkenstein

4

1 reference

12 May 2018

Olivier Chosidow

5

1 reference

12 May 2018

publication date

1 January 2008

1 reference

12 May 2018

published in

Dermatology

1 reference

12 May 2018

volume

216

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

46-55

1 reference

12 May 2018

Psoriasis causes as much disability as other major medical diseases

cites work

1 reference

Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

A comparison of treatment with dithranol and calcipotriol on the clinical severity and quality of life in patients with psoriasis.

21 January 2018

1 reference

Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria

21 January 2018

1 reference

Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study

21 January 2018

1 reference

Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study.

21 January 2018

1 reference

Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled trial of autologous blood therapy for atopic dermatitis

21 January 2018

1 reference

Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.

21 January 2018

1 reference

A randomized trial of etanercept as monotherapy for psoriasis.

21 January 2018

1 reference

Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.

21 January 2018

1 reference

Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis

21 January 2018

1 reference

Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis

21 January 2018

1 reference

Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial

21 January 2018

1 reference

A pilot study on the use of wet wraps in infants with moderate atopic eczema

21 January 2018

1 reference

Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.

21 January 2018

1 reference

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.

21 January 2018

1 reference

Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate

21 January 2018

1 reference

Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

21 January 2018

1 reference

Leflunomide improves psoriasis in patients with psoriatic arthritis: an in-depth analysis of data from the TOPAS study.

21 January 2018

1 reference

Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.

21 January 2018

1 reference

Autologous Whole Blood Injections to Patients with Chronic Urticaria and a Positive Autologous Serum Skin Test: A Placebo-Controlled Trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000109358

1 reference

12 May 2018

1 reference

12 May 2018